COMMUNIQUÉS West-GlobeNewswire

Advanced Accelerator Applications Signs Exclusive License Agreement with Cancer Targeted Technology to Develop CTT1057, an F-18 Labeled PSMA Ligand for Diagnostic Applications in Prostate Cancer

12/02/2018 - 13:00

SAINT-GENIS-POUILLY, France, Feb. 12, 2018 (GLOBE NEWSWIRE) -- Advanced Accelerator Applications S.A. (NASDAQ: AAAP ) (AAA or the Company), a Novartis company and leader in nuclear medicine theragnostics, today [...]

Foundation Fighting Blindness will provide up to $7.5 million in funding to develop ProQR’s candidate QR-421a for Usher syndrome type 2A

12/02/2018 - 13:00

Foundation Fighting Blindness and ProQR enter into a partnership to develop QR-421a for Usher syndrome type 2A, targeting mutations in exon 13 of the causative USH2A gene. Foundation Fighting Blindness will provide [...]

Akcea Therapeutics to Hold Fourth Quarter 2017 Financial Results Webcast

12/02/2018 - 13:00

CAMBRIDGE, Mass., Feb. 12, 2018 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc. (NASDAQ: AKCA ), an affiliate of Ionis Pharmaceuticals, Inc., focused on developing and commercializing drugs to treat patients with serious [...]

Axovant Sciences Announces Changes to Management Team and Board of Directors

12/02/2018 - 13:00

Dr. David Hung resigns as CEO and continues as scientific advisor to Roivant family of companies Dr. Pavan Cheruvu appointed as CEO of Axovant Dr. Roger Jeffs, former President and co-CEO of United Therapeutics, and [...]

Evogene Financial Results for the Fourth Quarter and Full Year 2017 Earnings Announcement Schedule

12/02/2018 - 13:00

REHOVOT, Israel, Feb. 12, 2018 (GLOBE NEWSWIRE) -- Evogene Ltd. (NASDAQ: EVGN )(TASE: EVGN ), a leading biotechnology company developing novel products for life science markets through the use of a unique computational [...]

Codexis to Present at the 25th International Molecular Medicine Tri-Conference

12/02/2018 - 13:00

REDWOOD CITY, Calif., Feb. 12, 2018 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS ), a leading protein engineering company, announces that John Nicols, President & CEO, will discuss the development of an improved [...]

Ziopharm Oncology Presents Data on Very Rapid Production of CAR T Cells at Keystone Symposia Emerging Cellular Therapies: T Cells and Beyond

12/02/2018 - 13:00

BOSTON, Feb. 12, 2018 (GLOBE NEWSWIRE) -- Ziopharm Oncology, Inc. (Nasdaq: ZIOP ), a biotechnology company focused on development of next generation immunotherapies utilizing gene- and cell-based therapies to treat [...]

ChromaDex Corporation Reports Preliminary 2017 Results

12/02/2018 - 12:30

IRVINE, Calif., Feb. 12, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corporation (NASDAQ: CDXC ), a science-based, integrated nutraceutical company devoted to pioneering technologies that improve the way people age, is providing [...]

ContraVir Pharmaceuticals Reaches Agreement with the FDA on the NDA Package for TXL™ Leveraging the 505(b)(2) Regulatory Pathway

12/02/2018 - 12:00

EDISON, N.J., Feb. 12, 2018 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV ), a biopharmaceutical company focused on the development and commercialization of targeted antiviral therapies, announced [...]

Genetic Technologies Limited: Update on Strategic Alliance

12/02/2018 - 11:00

MELBOURNE, Australia, Feb. 12, 2018 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG) (NASDAQ: GENE ) (“Company”, “GTG”), wishes to advise that the Company is presently in discussions with the ASX regarding the [...]

Herantis Pharma strengthens team - Outi Lahdenperä and Antti Vuolanto have joined Herantis

12/02/2018 - 08:00

Herantis Pharma strengthens team - Outi Lahdenperä and Antti Vuolanto have joined Herantis Herantis Pharma Plc Press release 12 Feb 2018 at 9:00 am Herantis Pharma plc ("Herantis") has strengthened its core team with [...]

PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")

12/02/2018 - 07:11

REGULATED INFORMATION GHENT, Belgium, 12 February 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major [...]

PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")

12/02/2018 - 07:01

REGULATED INFORMATION GHENT, Belgium, 12 February 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major [...]

Adamas Announces New Employment Inducement Grant

09/02/2018 - 23:26

EMERYVILLE, Calif., Feb. 09, 2018 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS ) today announced that the compensation committee of the company’s board of directors granted five new employees the [...]

Aurora Spine Completes Private Placement

09/02/2018 - 22:58

THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT AUTHORIZED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. CARLSBAD, Calif., Feb. 09, 2018 (GLOBE [...]

Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2018 Ended December 31, 2017

09/02/2018 - 22:57

NORTHVALE, N.J., Feb. 09, 2018 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB: ELTP ), a specialty pharmaceutical company developing abuse-deterrent opioids and niche generic products [...]

Cytori Therapeutics Announces Inducement Grants for New Employees

09/02/2018 - 22:45

SAN DIEGO, Feb. 09, 2018 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (NASDAQ: CYTX ) (the “Company”), announced today that the Compensation Committee of the Company's Board of Directors granted non-qualified stock [...]

AFA: Increased Spending at the NIH Paves the Way for a Much-Needed Boost to Funding for Alzheimer’s Research

09/02/2018 - 22:22

NEW YORK, Feb. 09, 2018 (GLOBE NEWSWIRE) -- Congressional leaders have agreed to a two-year budget package that calls for increasing spending at the National Institutes of Health (NIH) by $2 billion. This provides the [...]

HealthEquity’s Jon Soldan Named to Utah Business’ Forty Under 40

09/02/2018 - 22:04

DRAPER, Utah, Feb. 09, 2018 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY ), a leading health savings account (HSA) provider, is pleased to announce that its Executive Vice President of Operations, Jon Soldan, has [...]